PHARMASEAL

About:

PHARMASEAL is developing the first B2B control platform for biopharmaceutical companies to manage their enterprise clinical trials.

Website: http://www.pharmaseal.co/

Twitter/X: pharmaseal

Top Investors: Mercia Fund Managers, Midlands Engine Investment Fund, Pitch@Palace

Description:

PHARMASEAL was born in 2016 with the mission to create a digital platform that enables their customers to increase control of their clinical trials and accelerate product development. PHARMASEAL is developing the first B2B control platform for biopharmaceutical companies to manage their enterprise clinical trials.

Total Funding Amount:

2.1M GBP

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Nottingham, Nottingham, United Kingdom

Founded Date:

2016-10-10

Contact Email:

info(AT)pharmaseal.co

Founders:

Daljit Cheema

Number of Employees:

11-50

Last Funding Date:

2020-09-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai